Opendata, web and dolomites
H2020 projects about "hepatitis"
The page lists 32 projects related to the topic "hepatitis".
| # | |||
|---|---|---|---|
| 1 | CARBALIVE | Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. | 2015 |
| 2 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
| 3 | LiVirIn | 3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction | 2015 |
| 4 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
| 5 | HEPCIR | Cell circuits as targets and biomarkers for liver disease and cancer prevention | 2016 |
| 6 | HEP-CAR | Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. | 2016 |
| 7 | CMIL | Crosstalk of Metabolism and Inflammation | 2016 |
| 8 | CollBioImag | Development of a cell-based system for high-throughput screening of antifibrotics | 2016 |
| 9 | HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC | 2016 |
| 10 | THUNDER | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | 2017 |
| 11 | HBVssNMR | Investigating the structural role of the Hepatitis B virus core protein C-terminal domain in assembly and maturation using solid-state NMR | 2017 |
| 12 | PRELICAN | Treatment of liver disease and cancer prevention | 2017 |
| 13 | FATE | Functional Biology of Hepatic CD8+ T cells | 2017 |
| 14 | HEPASPHER | Mimicking liver disease and regeneration in vitro for drug development and liver transplantation | 2017 |
| 15 | VIRO-FLOW | Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors | 2017 |
| 16 | EASIVIRAL | EASIVIRAL | 2017 |
| 17 | HepaCheC | HepaCheC - an in vitro diagnostic assay for the early detection of liver cancer | 2018 |
| 18 | MISFIRES | Misfires and Market Innovation: Toward a Collaborative Turn in Organising Markets | 2018 |
| 19 | RNAfate | RNAfate- revealing regulation of cellular “noise”. | 2019 |
| 20 | Composite Gloves | Protective Composite Gloves for Health Care | 2018 |
| 21 | Safe-Blood | A cost and time effective blood test to detect multiple bloodborne diseases | 2018 |
| 22 | HIPShot | HBV GenetIc and Proteomic Screen | 2019 |
| 23 | SmartSyringe | SmartSyringe, world easiest, safest and fastest blood collection ever made. | 2018 |
| 24 | COCLICAN | COllaborative Consortium for the early detection of LIver CANcer | 2018 |
| 25 | VIRUSES AND RNA | RNA regulation during viral infection | 2019 |
| 26 | PanCaVax | Personalised Pancreatic Cancer Vaccination Therapy derived from Autologous Tumor Cells and Neoantigens | 2018 |
| 27 | ABT | AXVIRIUM BIOACTIVE TECNOLOGY_ The first medical device able to eliminate the fluids biological hazard | 2019 |
| 28 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
| 29 | SafeGlov | Safety Gloves for Protection of Health Care Professionals | 2019 |
| 30 | IP-cure-B | Immune profiling to guide host-directed interventions to cure HBV infections | 2020 |
| 31 | TherVacB | THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B | 2020 |
| 32 | LiverScreen | Screening for liver fibrosis - population-based study across European countries | 2020 |